The same study showed that anti-EA IgM levels were higher in NMO and MS patients compared to healthy controls, whereas antiviral capsid antigen and anti-EBNA IgG levels were higher in MS patients than in NMO patients or healthy individuals. This evidence concerns the gene CD40LG and myeloid sarcoma.